Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-01-15 Mohan Pankaj Director Purchase +8,000 $0.68 $5K 7,064,553
2018-11-09 Mohan Pankaj Director Grant or award · Stock Option (Right to Buy) +114,157 $0.61 $70K 114,157
2018-09-21 Mohan Pankaj Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2018-01-04 Mohan Pankaj President & CEO Sale −62,569 $1.16 $73K 7,056,553
2018-01-03 Mohan Pankaj President & CEO Sale −52,108 $1.18 $61K 7,119,122
2017-12-19 Mohan Pankaj President & CEO Sale −83,608 $1.14 $95K 7,171,230
2017-12-18 Mohan Pankaj President & CEO Sale −20,523 $1.17 $24K 7,254,838
2016-05-18 Mohan Pankaj President & CEO Conversion · Series A Preferred Stock −106 0
2016-05-11 Mohan Pankaj President & CEO Conversion +17,666 39,405

Page 1 of 1 · 9 trades